Ketogenic diet leads in metabolic health improvements for diabetic patients

Study compares the effects of very-low-calorie ketogenic and Mediterranean diets on gut microbiota, metabolic health, and weight management in patients with newly diagnosed type 2 diabetes and obesity.

Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052 – Biotech Investments

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the

November 21, 2023

Compass Pathways Lost Its Co-Founders – Now What? | Psychedelic Invest

In an unexpected turn of events, Compass Pathways plc (Nasdaq: CMPS), a leading figure in the mental health sector, witnessed a notable dip in its

April 2, 2024

The changing of the guard is expected in the Crohn’s disease marketplace – Pharmaceutical Technology

The future of CD therapy appears to be highly dynamic and competitive, with the advancement of developing novel mechanisms of action. Credit: Emily frost via

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.